The DOI matches its Crossref record; 274 of the 274 references it cites were found in a registry or an index.
Involvement of Astrocytes in Alzheimer’s Disease from a Neuroinflammatory and Oxidative Stress Perspective
Open accessAbstract
animal models. The presence of amyloid beta (Aβ) has been shown to disrupt gliotransmission, neurotransmitter uptake, and alter calcium signaling in astrocytes. Furthermore, astrocytes express apolipoprotein E and are involved in the production, degradation and removal of Aβ. As well, changes in astrocytes that precede other pathological characteristics observed in AD, point to an early contribution of astroglia in this disease. Astrocytes participate in the inflammatory/immune responses of the central nervous system. The presence of Aβ activates different cell receptors and intracellular signaling pathways, mainly the advanced glycation end products receptor/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway, responsible for the transcription of pro-inflammatory cytokines and chemokines in astrocytes. The release of these pro-inflammatory agents may induce cellular damage or even stimulate the production of Aβ in astrocytes. Additionally, Aβ induces the appearance of oxidative stress (OS) and production of reactive oxygen species and reactive nitrogen species in astrocytes, affecting among others, intracellular calcium levels, NADPH oxidase (NOX), NF-κB signaling, glutamate uptake (increasing the risk of excitotoxicity) and mitochondrial function. Excessive neuroinflammation and OS are observed in AD, and astrocytes seem to be involved in both. The Aβ/NF-κB interaction in astrocytes may play a central role in these inflammatory and OS changes present in AD. In this paper, we also discuss therapeutic measures highlighting the importance of astrocytes in AD pathology. Several new therapeutic approaches involving phenols (curcumin), phytoestrogens (genistein), neuroesteroids and other natural phytochemicals have been explored in astrocytes, obtaining some promising results regarding cognitive improvements and attenuation of neuroinflammation. Novel strategies comprising astrocytes and aimed to reduce OS in AD have also been proposed. These include estrogen receptor agonists (pelargonidin), Bambusae concretio Salicea, Monascin, and various antioxidatives such as resveratrol, tocotrienol, anthocyanins, and epicatechin, showing beneficial effects in AD models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971 · cited 2×
“In a recent paper, a new classification of reactive astrocytes was proposed, designating A1 those astrocytes that developed a neurotoxic phenotype and A2 those that depicted neurotrophic and neuroprotective characteristics (Liddelow et al., 2017).”
BackgroundThe amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Crosstalk of reactive oxygen species and NF-κB signaling
Morgan, M. J., & Liu, Z.-G. (2011) · Cell Research · doi:10.1038/cr.2010.178 · Cited by 3,505
Tripartite synapses: glia, the unacknowledged partner
Araque, A., Parpura, V., Sanzgiri, R. P., & Haydon, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01349-6 · Cited by 2,529 · cited 1×
“The concept of “tripartite synapse” refers to this cellular network involving both presynaptic and postsynaptic neurons, as well as astrocytes (Araque et al., 1999; Perea et al., 2009).”
BackgroundGenomic analysis of reactive astrogliosis
Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N., Zhou, L., Giffard, R. G., & Barres, B. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6221-11.2012 · Cited by 2,404 · cited 2×
“Furthermore, the reactive state of astrocytes may also depend on the source of injury (neuroinflammation or ischemia), indicating the complex range of responses these cells are capable to produce (Zamanian et al., 2012).”
BackgroundYang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
(2015) · HAL · Cited by 2,238
How neuroinflammation contributes to neurodegeneration
Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864
Tripartite synapses: astrocytes process and control synaptic information
Perea, G., Navarrete, M., & Araque, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.001 · Cited by 1,820 · cited 2×
“Different studies have shown that the cooperative activity between glia and neurons results in the modulation of cognitive functions (Perea et al., 2009; Fields et al., 2014).”
BackgroundLim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
A Cellular Perspective on Brain Energy Metabolism and Functional Imaging
Magistretti, P. J., & Allaman, I. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.035 · Cited by 1,285 · cited 2×
“…and participate in processes such as neurotransmitter uptake and recycling, gliotransmitter release, neuroenergetics, inflammation, modulation of synaptic activity, ionic balance, and maintenance of BBB, among others (Magistretti and Allaman, 2015; Iglesias et al., 2017; Vasile et al., 2017).”
BackgroundAstrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280
Mitochondria and calcium: from cell signalling to cell death
Duchen, M. R. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00057.x · Cited by 1,259
Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease
Kisler, K., Nelson, A. R., Montagne, A., & Zlokovic, B. V. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.48 · Cited by 1,243
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Bak, L. K., Schousboe, A., & Waagepetersen, H. S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03913.x · Cited by 1,114
Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders
Islam, M. T. (2017) · Neurological Research · doi:10.1080/01616412.2016.1251711 · Cited by 983
Fellin, T., Pascual, O., Gobbo, S., Pozzan, T., Haydon, P. G., & Carmignoto, G. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.011 · Cited by 969
Mechanism of Oxidative Stress in Neurodegeneration
Gandhi, S., & Abramov, A. Y. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/428010 · Cited by 960
Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C., & Sheng, M. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.015 · Cited by 943
Glia-Derived d-Serine Controls NMDA Receptor Activity and Synaptic Memory
Panatier, A., Theodosis, D. T., Mothet, J.-P., Touquet, B., Pollegioni, L., Poulain, D. A., & Oliet, S. H. R. (2006) · Cell · doi:10.1016/j.cell.2006.02.051 · Cited by 934
Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight
Bhat, A. H., Dar, K. B., Anees, S., Zargar, M. A., Masood, A., Sofi, M. A., & Ganie, S. A. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.07.025 · Cited by 928
Free radicals and antioxidants: updating a personal view
Halliwell, B. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00476.x · Cited by 912
Astrocytes: Key Regulators of Neuroinflammation
Colombo, E., & Farina, C. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.06.006 · Cited by 904
The genetic landscape of Alzheimer disease: clinical implications and perspectives
Van Cauwenberghe, C., Van Broeckhoven, C., & Sleegers, K. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.117 · Cited by 863 · cited 1×
“Among these factors are included: genetic, such as the presence of the APoE ε 4 allele, environmental, and several modifiable lifestyle factors (Killin et al., 2016; Van Cauwenberghe et al., 2016; Vos et al., 2017).”
BackgroundThe tripartite synapse: roles for gliotransmission in health and disease
Halassa, M. M., Fellin, T., & Haydon, P. G. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.12.005 · Cited by 852
Oxidative stress in brain agingImplications for therapeutics of neurodegenerative diseases
FLOYD, R., & HENSLEY, K. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00019-2 · Cited by 830
Glutamate exocytosis from astrocytes controls synaptic strength
Jourdain, P., Bergersen, L. H., Bhaukaurally, K., Bezzi, P., Santello, M., Domercq, M., Matute, C., Tonello, F., Gundersen, V., & Volterra, A. (2007) · Nature Neuroscience · doi:10.1038/nn1849 · Cited by 801
GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease
Jo, S., Yarishkin, O., Hwang, Y. J., Chun, Y. E., Park, M., Woo, D. H., Bae, J. Y., Kim, T., Lee, J., Chun, H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3639 · Cited by 783
Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., Oh, K. W., & Hong, J. T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-37 · Cited by 772
Astrocytes: a central element in neurological diseases
Pekny, M., Pekna, M., Messing, A., Steinhäuser, C., Lee, J.-M., Parpura, V., Hol, E. M., Sofroniew, M. V., & Verkhratsky, A. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1513-1 · Cited by 755
Neuron-glia metabolic coupling and plasticity
Magistretti, P. J. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2010.053157 · Cited by 747
Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease
Vossel, K. A., Beagle, A. J., Rabinovici, G. D., Shu, H., Lee, S. E., Naasan, G., Hegde, M., Cornes, S. B., Henry, M. L., Nelson, A. B., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.136 · Cited by 741
ALLANBUTTERFIELD, D., CASTEGNA, A., LAUDERBACK, C., & DRAKE, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00340-2 · Cited by 715
Sanchez, P. E., Zhu, L., Verret, L., Vossel, K. A., Orr, A. G., Cirrito, J. R., Devidze, N., Ho, K., Yu, G.-Q., Palop, J. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121081109 · Cited by 638
Functional diversity of astrocytes in neural circuit regulation
Haim, L. B., & Rowitch, D. H. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.159 · Cited by 618
Lanoiselée, H.-M., Nicolas, G., Wallon, D., Rovelet-Lecrux, A., Lacour, M., Rousseau, S., Richard, A.-C., Pasquier, F., Rollin-Sillaire, A., Martinaud, O., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002270 · Cited by 616
Oxidative stress in the progression of Alzheimer disease in the frontal cortex
Ansari, M. A., & Scheff, S. W. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181cb5af4 · Cited by 605
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Talantova, M., Sanz-Blasco, S., Zhang, X., Xia, P., Akhtar, M. W., Okamoto, S.-I., Dziewczapolski, G., Nakamura, T., Cao, G., Pratt, A. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306832110 · Cited by 600
Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease
Mosconi, L., Pupi, A., & De Leon, M. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.007 · Cited by 595
Abramov, A. Y., Canevari, L., & Duchen, M. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4042-03.2004 · Cited by 587
Jiang, T., Sun, Q., & Chen, S. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.07.005 · Cited by 586
Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides
Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1058 · Cited by 571
NF-κB Signaling: Multiple Angles to Target OA
B. Marcu, K., Otero, M., Olivotto, E., Maria Borzi, R., & B. Goldring, M. (2010) · Current Drug Targets · doi:10.2174/138945010791011938 · Cited by 565
Araque, A., Parpura, V., Sanzgiri, R. P., & Haydon, P. G. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00221.x · Cited by 541
Proteomic identification of nitrated proteins in Alzheimer's disease brain
Castegna, A., Thongboonkerd, V., Klein, J. B., Lynn, B., Markesbery, W. R., & Butterfield, D. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01786.x · Cited by 535
Contribution of astrocytes to hippocampal long-term potentiation through release of d -serine
Yang, Y., Ge, W., Chen, Y., Zhang, Z., Shen, W., Wu, C., Poo, M., & Duan, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2431073100 · Cited by 533
Mechanisms of Aβ Clearance and Degradation by Glial Cells
Ries, M., & Sastre, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00160 · Cited by 527 · cited 4×
“Astrocytes also express and secrete several MMPs, including MMP-2 and MMP-9, which degrade both monomeric and fibrillar extracellular forms of A β (Ries and Sastre, 2016).”
BackgroundInfluentialLevitt, P., Pintar, J. E., & Breakefield, X. O. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.20.6385 · Cited by 526
Butterfield, D. A., Swomley, A. M., & Sultana, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5027 · Cited by 526
Neuroprotective effects of curcumin
Cole, G. M., Teter, B., & Frautschy, S. A. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_8 · Cited by 516
A Portrait of Alzheimer Secretases--New Features and Familiar Faces
Esler, W. P., & Wolfe, M. S. (2001) · Science · doi:10.1126/science.1064638 · Cited by 493
The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease
Minter, M. R., Taylor, J. M., & Crack, P. J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13411 · Cited by 451
Carter, S. F., Schöll, M., Almkvist, O., Wall, A., Engler, H., Långström, B., & Nordberg, A. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.087031 · Cited by 442
Anti-inflammatory drugs and Alzheimer disease
Mcgeer, P., Mcgeer, E., Rogers, J., & Sibley, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91101-f · Cited by 437
Environmental risk factors for dementia: a systematic review
Killin, L. O. J., Starr, J. M., Shiue, I. J., & Russ, T. C. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0342-y · Cited by 434
Human astrocytes: structure and functions in the healthy brain
Vasile, F., Dossi, E., & Rouach, N. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1383-5 · Cited by 428
Human Astrocytes: Secretome Profiles of Cytokines and Chemokines
Choi, S. S., Lee, H. J., Lim, I., Satoh, J.-I., & Kim, S. U. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092325 · Cited by 408
Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice
Krstic, D., Madhusudan, A., Doehner, J., Vogel, P., Notter, T., Imhof, C., Manalastas, A., Hilfiker, M., Pfister, S., Schwerdel, C., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-151 · Cited by 400
Liao, Y.-F., Wang, B.-J., Cheng, H.-T., Kuo, L.-H., & Wolfe, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402034200 · Cited by 389 · cited 2×
“In general, TNF-α, IL-1β, IFN-γ, L-6, and TGF-β are able to stimulate β-secretase and γ-secretase enzymatic activity through a JNK-dependent MAPK pathway, which cleaves APP and initiates Aβ formation (Liao et al., 2004).”
Matrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-β Peptide Catabolism
Yin, K.-J., Cirrito, J. R., Yan, P., Hu, X., Xiao, Q., Pan, X., Bateman, R., Song, H., Hsu, F.-F., Turk, J., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2085-06.2006 · Cited by 381
Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ
Yan, P., Hu, X., Song, H., Yin, K., Bateman, R. J., Cirrito, J. R., Xiao, Q., Hsu, F. F., Turk, J. W., Xu, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602440200 · Cited by 380 · cited 2×
“Astrocytes also express and secrete several MMPs, including MMP-2 and MMP-9, which degrade both monomeric and fibrillar extracellular forms of A β (Ries and Sastre, 2016).”
BackgroundGarwood, C. J., Pooler, A. M., Atherton, J., Hanger, D. P., & Noble, W. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.50 · Cited by 379
Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis
Dasuri, K., Zhang, L., & Keller, J. N. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.016 · Cited by 371
The nuclear signaling of NF-κB: current knowledge, new insights, and future perspectives
Wan, F., & Lenardo, M. J. (2010) · Cell Research · doi:10.1038/cr.2009.137 · Cited by 370
Zhao, J., O'Connor, T., & Vassar, R. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-150 · Cited by 369
Role of Redox Signaling in Neuroinflammation and Neurodegenerative Diseases
Hsieh, H.-L., & Yang, C.-M. (2013) · BioMed Research International · doi:10.1155/2013/484613 · Cited by 365
Mendez, M. F. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.005 · Cited by 356
Tobon-Velasco, J., Cuevas, E., & Torres-Ramos, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140806144831 · Cited by 355
NMDA Receptors Mediate Neuron-to-Glia Signaling in Mouse Cortical Astrocytes
Lalo, U., Pankratov, Y., Kirchhoff, F., North, R. A., & Verkhratsky, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4689-05.2006 · Cited by 354
Regulation of Inducible Nitric Oxide Synthase Gene in Glial Cells
Saha, R. N., & Pahan, K. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.929 · Cited by 353
Akama, K. T., Albanese, C., Pestell, R. G., & Van Eldik, L. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5795 · Cited by 349
Abramov, A. Y., Canevari, L., & Duchen, M. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05088.2003 · Cited by 337
Reduced hippocampal metabolism in MCI and AD: Automated FDG-PET image analysis
Mosconi, L., Tsui, W. H., De Santi, S., Li, J., Rusinek, H., Convit, A., Li, Y., Boppana, M., & de Leon, M. J. (2005) · Neurology · doi:10.1212/01.wnl.0000163856.13524.08 · Cited by 336
Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis
Schrag, M., Mueller, C., Zabel, M., Crofton, A., Kirsch, W. M., Ghribi, O., Squitti, R., & Perry, G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.07.005 · Cited by 336
Multiple Roles for Astrocytes as Effectors of Cytokines and Inflammatory Mediators
Sofroniew, M. V. (2014) · The Neuroscientist · doi:10.1177/1073858413504466 · Cited by 333
Delekate, A., Füchtemeier, M., Schumacher, T., Ulbrich, C., Foddis, M., & Petzold, G. C. (2014) · Nature Communications · doi:10.1038/ncomms6422 · Cited by 332
Desgranges, B. (1998) · Brain · doi:10.1093/brain/121.4.611 · Cited by 329
Abdul, H. M., Sama, M. A., Furman, J. L., Mathis, D. M., Beckett, T. L., Weidner, A. M., Patel, E. S., Baig, I., Murphy, M. P., LeVine, H., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1064-09.2009 · Cited by 322
Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase
Brown, G. C. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351119 · Cited by 316
Bidirectional regulation of NF-κB by reactive oxygen species: A role of unfolded protein response
Nakajima, S., & Kitamura, M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.020 · Cited by 307
Laurent, C., Dorothée, G., Hunot, S., Martin, E., Monnet, Y., Duchamp, M., Dong, Y., Légeron, F.-P., Leboucher, A., Burnouf, S., et al. (2017) · Brain · doi:10.1093/brain/aww270 · Cited by 303
Rodriguez-Vieitez, E., Saint-Aubert, L., Carter, S. F., Almkvist, O., Farid, K., Schöll, M., Chiotis, K., Thordardottir, S., Graff, C., Wall, A., et al. (2016) · Brain · doi:10.1093/brain/awv404 · Cited by 300
Lue, L. F., Brachova, L., CIVIN, W. H., & Rogers, J. (1996) · PubMed · Cited by 299
Akama, K. T., & Van Eldik, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7918 · Cited by 287
Rehman, S. U., Shah, S. A., Ali, T., Chung, J. I., & Kim, M. O. (2017) · Molecular Neurobiology · doi:10.1007/s12035-015-9604-5 · Cited by 287
Westin, K., Buchhave, P., Nielsen, H., Minthon, L., Janciauskiene, S., & Hansson, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030525 · Cited by 277
Komori, T. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00549.x · Cited by 277
Falkowska, A., Gutowska, I., Goschorska, M., Nowacki, P., Chlubek, D., & Baranowska-Bosiacka, I. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125939 · Cited by 277
Enhanced Astrocytic Ca2+Signals Contribute to Neuronal Excitotoxicity after Status Epilepticus
Ding, S., Fellin, T., Zhu, Y., Lee, S.-Y., Auberson, Y. P., Meaney, D. F., Coulter, D. A., Carmignoto, G., & Haydon, P. G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2001-07.2007 · Cited by 270
(2006) · PubMed · Cited by 269
Wang, J., Tan, L., Wang, H.-F., Tan, C.-C., Meng, X.-F., Wang, C., Tang, S.-W., & Yu, J.-T. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141506 · Cited by 266
Salvatore, C., Cerasa, A., Battista, P., Gilardi, M. C., Quattrone, A., & Castiglioni, I. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00307 · Cited by 265
Verkhratsky, A., & Kirchhoff, F. (2007) · The Neuroscientist · doi:10.1177/1073858406294270 · Cited by 265
Verdier, Y., Zarándi, M., & Penke, B. (2004) · Journal of Peptide Science · doi:10.1002/psc.573 · Cited by 262
Hu, J., Akama, K. T., Krafft, G. A., Chromy, B. A., & Van Eldik, L. J. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01318-8 · Cited by 262
Astrocytes Couple Synaptic Activity to Glucose Utilization in the Brain
Magistretti, P. J., & Pellerin, L. (1999) · Physiology · doi:10.1152/physiologyonline.1999.14.5.177 · Cited by 261
Blasko, I., Veerhuis, R., Stampfer-Kountchev, M., Saurwein-Teissl, M., Eikelenboom, P., & Grubeck-Loebenstein, B. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0321 · Cited by 258
Soucek, T., Cumming, R., Dargusch, R., Maher, P., & Schubert, D. (2003) · Neuron · doi:10.1016/s0896-6273(03)00367-2 · Cited by 258
Apelt, J., & Schliebs, R. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03176-0 · Cited by 257
Amyloid-β Receptors: The Good, the Bad, and the Prion Protein
Jarosz-Griffiths, H. H., Noble, E., Rushworth, J. V., & Hooper, N. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.702704 · Cited by 256
Targeting neuroinflammation in Alzheimer’s disease
Bronzuoli, M. R., Iacomino, A., Steardo, L., & Scuderi, C. (2016) · Journal of Inflammation Research · doi:10.2147/jir.s86958 · Cited by 255
Prevention and management of dementia: a priority for public health
Frankish, H., & Horton, R. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31756-7 · Cited by 249
Astrocyte dysfunction in Alzheimer disease
Acosta, C., Anderson, H. D., & Anderson, C. M. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24075 · Cited by 247
Lue, L.-F., Brachova, L., Civin, H. W., & Rogers, J. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199655100-00008 · Cited by 246 · cited 1×
“The pathological study of brains from individuals with AD has revealed the presence of both neuroinflammation and OS (Lue et al., 1996; Ansari and Scheff, 2010).”
BackgroundNeuroinflammation: Ways in Which the Immune System Affects the Brain
Ransohoff, R. M., Schafer, D., Vincent, A., Blachère, N. E., & Bar-Or, A. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0385-3 · Cited by 243
Müller, W. E., Eckert, A., Kurz, C., Eckert, G. P., & Leuner, K. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8141-5 · Cited by 243
Morgello, S., Uson, R. R., Schwartz, E. J., & Haber, R. S. (1995) · Glia · doi:10.1002/glia.440140107 · Cited by 238
Amyloid beta peptides and glutamatergic synaptic dysregulation
Parameshwaran, K., Dhanasekaran, M., & Suppiramaniam, V. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.008 · Cited by 235
Expression of interleukin-18 is increased in the brains of Alzheimer’s disease patients
Ojala, J., Alafuzoff, I., Herukka, S.-K., van Groen, T., Tanila, H., & Pirttilä, T. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.006 · Cited by 235
Hertz, L. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00059 · Cited by 234
Glial Biology in Learning and Cognition
Fields, R. D., Araque, A., Johansen-Berg, H., Lim, S.-S., Lynch, G., Nave, K.-A., Nedergaard, M., Perez, R., Sejnowski, T., & Wake, H. (2014) · The Neuroscientist · doi:10.1177/1073858413504465 · Cited by 232
Norris, C. M., Kadish, I., Blalock, E. M., Chen, K.-C., Thibault, V., Porter, N. M., Landfield, P. W., & Kraner, S. D. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0365-05.2005 · Cited by 229
Merlini, M., Meyer, E. P., Ulmann-Schuler, A., & Nitsch, R. M. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0834-y · Cited by 225
Walls, A. B., Waagepetersen, H. S., Bak, L. K., Schousboe, A., & Sonnewald, U. (2015) · Neurochemical Research · doi:10.1007/s11064-014-1473-1 · Cited by 223
Abramov, A. Y., Canevari, L., & Duchen, M. R. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.006 · Cited by 223
Takeda, S., Sato, N., & Morishita, R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00171 · Cited by 223
APOE ε4/ε4 diminishes neurotrophic function of human iPSC-derived astrocytes
Zhao, J., Davis, M. D., Martens, Y. A., Shinohara, M., Graff-Radford, N. R., Younkin, S. G., Wszolek, Z. K., Kanekiyo, T., & Bu, G. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx155 · Cited by 221
Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease
Farfara, D., Lifshitz, V., & Frenkel, D. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00314.x · Cited by 216 · cited 2×
“RAGE, Astrocytes, and Amyloid Beta Amyloid beta has been reported to interact with numerous cellular receptors and astrocytes express a large amount of them, including TLRs, scavenger receptors, glycoprotein receptors, lipoprotein receptors, RAGE, acetylcholine receptors, complement and chemokine receptors, T-cell rec…”
BackgroundWebster, M. J., O’Grady, J., Kleinman, J. E., & Weickert, C. S. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.02.037 · Cited by 208
Dysfunctional synapse in Alzheimer's disease – A focus on NMDA receptors
Mota, S. I., Ferreira, I. L., & Rego, A. C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.013 · Cited by 206
Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures
Del Bo, R., Angeretti, N., Lucca, E., De Simoni, M. G., & Forloni, G. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11384-9 · Cited by 205
Gulyás, B., Pavlova, E., Kása, P., Gulya, K., Bakota, L., Várszegi, S., Keller, É., Horváth, M. C., Nag, S., Hermecz, I., et al. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.10.013 · Cited by 202
NF-κB functions in the nervous system: From development to disease
Mémet, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.09.003 · Cited by 201
Transgenic Mouse Model of Tau Pathology in Astrocytes Leading to Nervous System Degeneration
Forman, M. S., Lal, D., Zhang, B., Dabir, D. V., Swanson, E., Lee, V. M.-Y., & Trojanowski, J. Q. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0081-05.2005 · Cited by 198 · cited 2×
“, 2005), as well as neurodegenerative diseases, including AD (Forman et al., 2005; Halassa et al., 2007).”
BackgroundMehlhorn, G., Hollborn, M., & Schliebs, R. (2000) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(00)00012-5 · Cited by 198
Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers
Arispe, N., Diaz, J. C., & Simakova, O. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.03.014 · Cited by 193
Alberdi, E., Wyssenbach, A., Alberdi, M., Sánchez‐Gómez, M. V., Cavaliere, F., Rodríguez, J. J., Verkhratsky, A., & Matute, C. (2013) · Aging Cell · doi:10.1111/acel.12054 · Cited by 190
Arispe, N., & Doh, M. (2002) · The FASEB Journal · doi:10.1096/fj.02-0829com · Cited by 189
The NF-κB/Rel family of proteins mediates Aβ-induced neurotoxicity and glial activation
Bales, K. R., Du, Y., Dodel, R. C., Yan, G.-M., Hamilton-Byrd, E., & Paul, S. M. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00066-7 · Cited by 188
Raskin, J., Cummings, J., Hardy, J., Schuh, K., & Dean, R. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150701103107 · Cited by 188
The nuclear signaling of NF-KB: current knowledge, new insights, and future perspectives
Fengyi, Wan, Michael, M., & Lenardo (2010) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 188
Characterisation of the Expression of NMDA Receptors in Human Astrocytes
Lee, M.-C., Ting, K. K., Adams, S., Brew, B. J., Chung, R., & Guillemin, G. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014123 · Cited by 185
Lüth, H.-J., Holzer, M., Gärtner, U., Staufenbiel, M., & Arendt, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02758-5 · Cited by 183
Gitter, B. D., Cox, L. M., Rydel, R. E., & May, P. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10738 · Cited by 178
Pereira Diniz, L., Tortelli, V., Matias, I., Morgado, J., Bérgamo Araujo, A. P., Melo, H. M., Seixas da Silva, G. S., Alves-Leon, S. V., de Souza, J. M., Ferreira, S. T., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3351-16.2017 · Cited by 171
Swomley, A. M., & Butterfield, D. A. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1556-z · Cited by 170
Amyloid beta deregulates astroglial mGluR5‐mediated calcium signaling via calcineurin and Nf‐kB
Lim, D., Iyer, A., Ronco, V., Grolla, A. A., Canonico, P. L., Aronica, E., & Genazzani, A. A. (2013) · Glia · doi:10.1002/glia.22502 · Cited by 169
Robinson, S. R. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00150-3 · Cited by 166
Dá Mesquita, S., Ferreira, A. C., Sousa, J. C., Correia-Neves, M., Sousa, N., & Marques, F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.014 · Cited by 166
Matos, M., Augusto, E., Machado, N. J., dos Santos‐Rodrigues, A., Cunha, R. A., & Agostinho, P. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120469 · Cited by 162
Abbas, N., Bednar, I., Mix, E., Marie, S., Paterson, D., Ljungberg, A., Morris, C., Winblad, B., Nordberg, A., & Zhu, J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00050-4 · Cited by 161
Vos, S. J. B., van Boxtel, M. P. J., Schiepers, O. J. G., Deckers, K., de Vugt, M., Carrière, I., Dartigues, J.-F., Peres, K., Artero, S., Ritchie, K., et al. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161208 · Cited by 161
Palygin, O., Lalo, U., Verkhratsky, A., & Pankratov, Y. (2010) · Cell Calcium · doi:10.1016/j.ceca.2010.09.004 · Cited by 160
The critical need for defining preclinical biomarkers in Alzheimer's disease
Fiandaca, M. S., Mapstone, M. E., Cheema, A. K., & Federoff, H. J. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.015 · Cited by 159
Kim, Y. E., Hwang, C. J., Lee, H. P., Kim, C. S., Son, D. J., Ham, Y. W., Hellström, M., Han, S.-B., Kim, H. S., Park, E. K., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.025 · Cited by 158
Liu, Z., Li, Z., Liu, L., Tang, W., Wang, Y., Dong, M., & Xiao, C. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00261 · Cited by 156
Transforming Growth Factor-β1 Potentiates Amyloid-β Generation in Astrocytes and in Transgenic Mice
Lesné, S., Docagne, F., Gabriel, C., Liot, G., Lahiri, D. K., Buée, L., Plawinski, L., Delacourte, A., MacKenzie, E. T., Buisson, A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300819200 · Cited by 151
Furuta, A., Price, D. L., Pardo, C. A., Troncoso, J. C., Xu, Z., Taniguchi, N., & Martin, L. J. (1995) · Europe PMC (PubMed Central) · Cited by 151
Schöll, M., Carter, S. F., Westman, E., Rodriguez‐Vieitez, E., Almkvist, O., Þórðardóttir, S., Wall, A. E., Graff, C., Långström, B., & Nordberg, A. K. (2015) · Scientific Reports · doi:10.1038/srep16404 · Cited by 150
Amyloid-β-Induced Astrocytic Phagocytosis is Mediated by CD36, CD47 and RAGE
Jones, R. S., Minogue, A. M., Connor, T. J., & Lynch, M. A. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9427-3 · Cited by 147 · cited 1×
“Furthermore, astrocytes have been reported to adopt a phagocytic profile capable of engulfing A β , mediated by CD36, CD47, and RAGE receptors (Jones et al., 2013).”
BackgroundChang, Y., Chang, W., Tsai, N., Huang, C., Kung, C., Su, Y., Lin, W.-C., Cheng, B., Su, C.-M., Chiang, Y.-F., et al. (2014) · BioMed Research International · doi:10.1155/2014/182303 · Cited by 147
Activation and intrinsic γ-secretase activity of presenilin 1
Ahn, K., Shelton, C. C., Tian, Y., Zhang, X., Gilchrist, M. L., Sisodia, S. S., & Li, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013246107 · Cited by 146
Viña, J., Lloret, A., Ortí, R., & Alonso, D. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.02.013 · Cited by 145
Nunomura, A., Tamaoki, T., Motohashi, N., Nakamura, M., McKeel, D. W., Tabaton, M., Lee, H., Smith, M. A., Perry, G. L., & Zhu, X. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318248e614 · Cited by 141
Distinct pharmacological and functional properties of NMDA receptors in mouse cortical astrocytes
Palygin, O., Lalo, U., & Pankratov, Y. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01374.x · Cited by 140
Mitochondrial dysfunction and Alzheimer's disease
Maruszak, A., & Żekanowski, C. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.004 · Cited by 140
Monoamine oxidase‐B in astrocytes
Ekblom, J., Jossan, S. S., Bergstrüm, M., Oreland, L., Walum, E., & Aquilonius, S. (1993) · Glia · doi:10.1002/glia.440080208 · Cited by 139
Altered synapses and gliotransmission in Alzheimer's disease and AD model mice
Mitew, S., Kirkcaldie, M. T. K., Dickson, T. C., & Vickers, J. C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.010 · Cited by 138
Metabolic and inflammatory adaptation of reactive astrocytes: role of PPARs
Iglesias, J., Morales, L., & Barreto, G. E. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9833-2 · Cited by 137
Impaired Autophagy in APOE4 Astrocytes
Simonovitch, S., Schmukler, E., Bespalko, A., Iram, T., Frenkel, D., Holtzman, D. M., Masliah, E., Michaelson, D. M., & Pinkas-Kramarski, R. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-151101 · Cited by 136
Carrero, I., Gonzalo, M. R., Martin, B., Sanz-Anquela, J. M., Arévalo-Serrano, J., & Gonzalo-Ruiz, A. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.05.004 · Cited by 132
The Alzheimer's Disease Anti-inflammatory Prevention Trial Research Group (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.11.012 · Cited by 131
Evaluation of rage isoforms, ligands, and signaling in the brain
Ding, Q., & Keller, J. N. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.08.006 · Cited by 130
Phospholipases A2Mediate Amyloid-β Peptide-Induced Mitochondrial Dysfunction
Zhu, D., Lai, Y., Shelat, P. B., Hu, C., Sun, G. Y., & Lee, J. C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3505-06.2006 · Cited by 128
Physiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2
Yan, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00097 · Cited by 127
Millington, C., Sonego, S., Karunaweera, N., Rangel, A., Aldrich-Wright, J. R., Campbell, I. L., Gyengési, E., & Münch, G. W. (2014) · BioMed Research International · doi:10.1155/2014/309129 · Cited by 126
Upstream regulators and downstream effectors of NF-κB in Alzheimer’s disease
Shi, Z.-M., Han, Y.-W., Han, X.-H., Zhang, K., Chang, Y.-N., Hu, Z.-M., Qi, H.-X., Ting, C., Zhen, Z., & Hong, W. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.05.022 · Cited by 125
Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
Huynh, R. A., & Mohan, C. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00102 · Cited by 125
Expression of the Small Heat-Shock Protein αB-Crystallin in Tauopathies with Glial Pathology
Dabir, D. V., Trojanowski, J. Q., Richter‐Landsberg, C., Lee, V. M. ‐., & Forman, M. S. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63106-9 · Cited by 123
GABA Transporters and GABA-Transaminase as Drug Targets
Sarup, A., Larsson, O. M., & Schousboe, A. (2003) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007033482788 · Cited by 122
Szekely, C. A., Green, R. C., Breitner, J. C. S., Østbye, T., Beiser, A. S., Corrada, M. M., Dodge, H. H., Ganguli, M., Kawas, C. H., Kuller, L. H., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000313933.17796.f6 · Cited by 121
Astrocytes in Alzheimer's Disease: Emerging Roles in Calcium Dysregulation and Synaptic Plasticity
Vincent, A. J., Gasperini, R., Foa, L. C., & Small, D. H. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101089 · Cited by 121
Nava-Mesa, M. O., Jiménez‐Díaz, L., Yajeya, J., & Navarro‐López, J. D. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00167 · Cited by 120
Self-citationHaughey, N. J., & Mattson, M. P. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:3:173 · Cited by 119
Ayasolla, K., Khan, M., Singh, A. K., & Singh, I. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.007 · Cited by 118
The blood brain barrier in Alzheimer’s disease
Chakraborty, A., de Wit, N. M., van der Flier, W. M., & de Vries, H. E. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2016.11.008 · Cited by 118
Šimić, G., Lucassen, P. J., Krsnik, Ž., Krušlin, B., Kostović, I., Winblad, B. G., & Bogdanović, N. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7448 · Cited by 115
Bonet-Costa, V., Herranz‐Pérez, V., Blanco-Gandía, M. C., Mas‐Bargues, C., Inglés, M., García-Tárraga, P., Rodríguez‐Arias, M., Miñarro, J., Borrás, C., García‐Verdugo, J. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151020 · Cited by 114
Wang, G., Chen, L., Pan, X., Chen, J., Wang, L., Wang, W., Cheng, R., Wu, F., Feng, X., Yu, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8041 · Cited by 114
Aβ Internalization by Neurons and Glia
Mohamed, A., & Chaves, E. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/127984 · Cited by 113
High resolution dissection of reactive glial nets in Alzheimer’s disease
Bouvier, D. S., Jones, E. V., Quesseveur, G., Davoli, M. A., A. Ferreira, T., Quirion, R., Mechawar, N., & Murai, K. K. (2016) · Scientific Reports · doi:10.1038/srep24544 · Cited by 111
The Essential Role of Soluble Aβ Oligomers in Alzheimer’s Disease
Wang, Z.-X., Tan, L., Liu, J., & Yu, J.-T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9143-0 · Cited by 110
Neuroinflammation, immune system and Alzheimer disease: searching for the missing link
Guerriero, F., Sgarlata, C. S., Francis, M., Maurizi, N., Faragli, A., Perna, S., Rondanelli, M., Rollone, M., & Ricevuti, G. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0637-z · Cited by 110
Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease
García‐Blanco, A., Baquero, M., Vento, M., Gil, E., Bataller, L., & Cháfer‐Pericás, C. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.01.020 · Cited by 110
Chiarini, A., Armato, U., Gardenal, E., Gui, L., & Prà, I. D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00217 · Cited by 109
Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
Libro, R., Giacoppo, S., Soundara Rajan, T., Bramanti, P., & Mazzon, E. (2016) · Molecules · doi:10.3390/molecules21040518 · Cited by 107
Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type
Prince, G. L., Delaère, P., Fages, C., Lefrançois, T., Touret, M., Salanon, M., & Tardy, M. (1995) · Neurochemical Research · doi:10.1007/bf00969698 · Cited by 107
Pirttimaki, T. M., Codadu, N. K., Awni, A., Pratik, P., Nagel, D. A., Hill, E. J., Dineley, K. T., & Parri, H. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081828 · Cited by 103 · cited 1×
“For instance, hippocampal astrocytes exposed to A β increased the frequency of NMDA receptor-mediated slow inward currents, together with calcium elevations mediated through α 7nAChR activation (Pirttimaki et al., 2013).”
BackgroundMulder, S. D., Veerhuis, R., Blankenstein, M. A., & Nielsen, H. M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.001 · Cited by 102
Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease
Dorfman, V. B., Pasquini, L. A., Riudavets, M. A., López‐Costa, J. J., Villegas, A., Troncoso, J. C., Lopera, F. J., Castaño, E. M., & Morelli, L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.016 · Cited by 101
Astrocytes: New Targets for the Treatment of Neurodegenerative Diseases
Finsterwald, C., Magistretti, P. J., & Lengacher, S. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150710144502 · Cited by 100
Echeverría, V., Iarkov, A., & Aliev, G. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.002 · Cited by 100
Aβ leads to Ca2+ signaling alterations and transcriptional changes in glial cells
Grolla, A. A., Fakhfouri, G., Balzaretti, G., Marcello, E. E., Gardoni, F., Canonico, P. L., Luca, M. D., Genazzani, A. A., & Lim, D. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.005 · Cited by 98
Minocycline attenuates bone cancer pain in rats by inhibiting NF-κB in spinal astrocytes
Song, Z., Xiong, B., Guan, X., Cao, F., Manyande, A., Zhou, Y., Zheng, H., & Tian, Y. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.1 · Cited by 97
Cited by
Simpson, D. S. A., & Oliver, P. L. (2020) · Antioxidants · doi:10.3390/antiox9080743 · Cited by 1,044
Sadick, J. S., O’Dea, M. R., Hasel, P., Dykstra, T., Faustin, A., & Liddelow, S. A. (2022) · Neuron · doi:10.1016/j.neuron.2022.03.008 · Cited by 415
Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1
Gomes, B. A. Q., Silva, J. P. B., Romeiro, C. F. R., dos Santos, S. M., Rodrigues, C. A., Gonçalves, P. R., Sakai, J. T., Mendes, P. F. S., Varela, E. L. P., & Monteiro, M. C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8152373 · Cited by 403
The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease
Sun, E., Motolani, A., Campos, L., & Lu, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168972 · Cited by 361
Astrocytes: Role and Functions in Brain Pathologies
Siracusa, R., Fusco, R., & Cuzzocrea, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01114 · Cited by 340
Metadata
- Authors
- González-Reyes, R. E., Nava-Mesa, M. O., Vargas-Sánchez, K., Ariza-Salamanca, D., & Mora-Muñoz, L.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-12-19
- Volume
- 10
- Pages
- 427-427
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2776096008
- Cited by
- 527
- References
- 274
- FWCI
- 24.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.